Apotex to Issue Refunds to 340B Covered Entities 

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Providers Take Issue with CMS Draft Guidance on IRA Implementation Calling It “Problematic, Unworkable and Inconsistent”

340B provider groups strongly criticized the Centers for Medicare & Medicaid Services’ draft guidance for Medicare drug price negotiations.
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Astellas Suspends its Contract Pharmacy Restrictions in More States; BMS and Sanofi Also Announce State Exemptions

Astellas building mounted sign
Astellas Pharma announced the suspension of its contract pharmacy policy in Maryland and Mississippi.
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie, AstraZeneca Sue Minnesota Over Contract Pharmacy Access Law

AbbVie and AstraZeneca filed a pair of lawsuits to block Minnesota's law barring manufacturer 340B contract pharmacy restrictions.
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

AbbVie, AstraZeneca Challenge Kansas’ New Contract Pharmacy Access Law

AbbVie will no longer offer voluntary 340B pricing on any of its orphan-designated drugs to covered entities subject to such exclusions.
Two major drug manufacturers this week sued Kansas in an effort to block the state’s new contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Urge Federal Court to Uphold Maryland’s 340B Contract Pharmacy Access Law

American Hospital Association logo
The American Hospital Association (AHA), 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers urged a federal judge to reject Novartis’ attempt to block Maryland’s new 340B contract pharmacy access law.
Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospitals in Texas and Other States Sue HHS Over DSH Calculation Changes That Impact 340B Eligibility

Dozens of hospitals in Texas and other states have filed suit against HHS to block a rule that they say lowers their disproportionate share hospital adjustment percentage and could result in a loss of 340B discounts.
Dozens of hospitals in Texas and other states have filed suits against Department of Health and Human Services (HHS) Secretary [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New York Times Sues HRSA To Release 340B Data, Communications Between Office of Pharmacy Affairs and Apexus Leaders; Information Could Be Released Soon

The New York Times has filed suit in the U.S. District Court for the Southern District of New York against the Health Resources and Services Administration to obtain an order requiring the production of 340B-related records requested in November 2023 under the Freedom of Information Act.
The New York Times has sued the federal agency tasked with overseeing the 340B program to force the release of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Days Before New Laws Go Into Effect, GSK, Pfizer Exempt Additional States from Contract Pharmacy Restrictions

GlaxoSmithKline wordmark and GSK logo on a building
GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.
Correction, Thursday, July 27, 2024, 7:00 p.m. EDT—The original version of this article mistakenly said Minnesota’s contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Association Pans ASAP 340B-Endorsed Bill, Encourages Congress to Support 340B PATIENTS Act

California
The California Hospital Association argued in a June 20 letter to the state’s congressional delegation that “core provisions” of the 340B Affording Care for Communities and Ensuring a Strong Safety-Net (340B ACCESS) Act “will reduce access to care for vulnerable populations.”
The California Hospital Association (CHA) is the latest organization to raise concerns about the 340B ACCESS Act, a bill recently [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live